Enveric Biosciences, Inc. Quarterly Amortization of Intangible Assets in USD from Q2 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Enveric Biosciences, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2014 to Q3 2024.
  • Enveric Biosciences, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $42.2K, a 0.01% decline year-over-year.
  • Enveric Biosciences, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $169K, a 0% increase year-over-year.
  • Enveric Biosciences, Inc. annual Amortization of Intangible Assets for 2023 was $169K, a 0% increase from 2022.
  • Enveric Biosciences, Inc. annual Amortization of Intangible Assets for 2022 was $169K, a 73.8% decline from 2021.
  • Enveric Biosciences, Inc. annual Amortization of Intangible Assets for 2021 was $643K, a 432% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $169K $42.2K -$3 -0.01% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $169K $42.2K +$1.00 +0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $169K $42.2K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $169K $42.2K +$4.00 +0.01% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $169K $42.2K $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $169K $42.2K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $169K $42.2K $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $169K $42.2K -$120K -74% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $289K $42.2K -$129K -75.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $417K $42.2K -$132K -75.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $549K $42.2K -$94.5K -69.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $643K $162K Oct 1, 2021 Dec 31, 2021 10-K/A 2023-06-09
Q3 2021 $171K +$171K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $174K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $137K -$363K -72.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q1 2020 $500K -$100K -16.7% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-15
Q1 2019 $600K -$200K -25% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q1 2018 $800K +$100K +14.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q1 2017 $700K +$603K +622% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q1 2016 $97K +$90.8K +1452% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-16
Q2 2015 $6.25K $0 0% Apr 1, 2015 Jun 30, 2015 10-Q/A 2015-08-18
Q1 2015 $6.25K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q2 2014 $6.25K Apr 1, 2014 Jun 30, 2014 10-Q 2015-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.